Iovance Biotherapeutics, Inc. (IOVA) vs Legend Biotech Corporation Sponsored ADR (LEGN)

Iovance Biotherapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR is the larger, with a market value of $4.4B against $3.5B — 1.2× the size. Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against 51.3%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −58.2%) and the higher return on invested capital (−9.54% vs −17.7%). Across the 17 metrics below, Legend Biotech Corporation Sponsored ADR leads on 13 and Iovance Biotherapeutics, Inc. on 4.

Valuation

Metric IOVA LEGN Biotechnology median
P/E n/m n/m 10.60
P/S 9.49 3.45 9.40
P/B 4.43 3.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.71 2.95 9.02
Earnings yield (6.63%) (2.11%) (32.88%)
Free cash flow yield (6.01%) (2.79%) (23.13%)

Profitability

Metric IOVA LEGN Biotechnology median
Gross margin 0.00% 56.58% 68.51%
Operating margin (60.79%) (5.06%) 0.00%
Net margin (58.19%) (7.20%) 0.00%
Free cash flow margin (57.01%) (9.58%) 0.00%
Return on equity (29.11%) (8.08%) (51.96%)
Return on assets (23.26%) (5.32%) (46.06%)
Return on invested capital (17.72%) (9.54%) 0.00%

Growth

Metric IOVA LEGN Biotechnology median
Revenue growth (TTM) 51.34% 59.55% 6.76%
EPS growth (last fiscal year) 14.84% (66.34%) 29.88%
Revenue growth, 5-year CAGR — 65.93% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOVA LEGN Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 5.20 3.04 4.97
Net debt to EBITDA 0.82 2.31 1.01

Dividend

Metric IOVA LEGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IOVA LEGN Biotechnology median
Market cap 3.51b 4.37b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack